checkAd

     133  0 Kommentare eFFECTOR Therapeutics Announces $15 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules - Seite 3

    Contacts:
    		    
         
    Investors:   Media:
    Christopher M. Calabrese Kevin Gardner Mike Tattory
    Managing Director Managing Director Account Supervisor
    LifeSci Advisors LifeSci Advisors LifeSci Communications
    917-680-5608 617-283-2856 609-802-6265
    ccalabrese@lifesciadvisors.com kgardner@lifesciadvisors.com mtattory@lifescicomms.com

    Seite 3 von 3




    globenewswire
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors

    Verfasst von globenewswire
    eFFECTOR Therapeutics Announces $15 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules - Seite 3 SOLANA BEACH, Calif. and REDWOOD CITY, Calif., Jan. 25, 2024 (GLOBE NEWSWIRE) - eFFECTOR Therapeutics, Inc. (NASDAQ: EFTR) (the “Company”), a leader in the development of selective translation regulator inhibitors (“STRIs”) for the treatment of …